Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion type Assertion NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_head.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion description "[Using these four risk factors, a new prognostic model for overall (high risk, RR 4.4, 95% CI 2.9-6.7; intermediate risk, RR 2.0, 95% CI 1.4-2.9) and leukemia-free survival (high risk, RR 4.9, 95% CI 1.9-12.8; intermediate risk, RR 2.6, 95% CI 1.1-5.9) performed better than other conventional risk models and was validated in an independent cohort of 268 CMML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_provenance.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion evidence source_evidence_literature NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_provenance.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion SIO_000772 23531518 NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_provenance.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion wasDerivedFrom befree-20140225 NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_provenance.
- NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_assertion wasGeneratedBy ECO_0000203 NP686630.RAp_dCsV58wh_72nc0__S_aHxDcU2zoR0eJNGDBG11zI0130_provenance.